[go: up one dir, main page]

WO2010072398A3 - Formulations vétérinaires - Google Patents

Formulations vétérinaires Download PDF

Info

Publication number
WO2010072398A3
WO2010072398A3 PCT/EP2009/009196 EP2009009196W WO2010072398A3 WO 2010072398 A3 WO2010072398 A3 WO 2010072398A3 EP 2009009196 W EP2009009196 W EP 2009009196W WO 2010072398 A3 WO2010072398 A3 WO 2010072398A3
Authority
WO
WIPO (PCT)
Prior art keywords
alcohol
buprenorphine
pharmaceutical formulations
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/009196
Other languages
English (en)
Other versions
WO2010072398A2 (fr
Inventor
Philip Watson
Claire Fowler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Ltd
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of WO2010072398A2 publication Critical patent/WO2010072398A2/fr
Publication of WO2010072398A3 publication Critical patent/WO2010072398A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une formulation pharmaceutique comprenant de la buprénorphine ou l'un de ses sels pharmaceutiquement acceptables et un alcool, ladite formulation contenant une concentration ≤ 1 % p/v de buprénorphine ou de son sel ; et une formulation pharmaceutique comprenant de la buprénorphine ou l'un de ses sels pharmaceutiquement acceptables et un alcool, ladite formulation contenant une concentration ≤ 3 % p/v d'alcool. L'invention concerne également l'utilisation desdites préparations en tant qu'antalgiques ou sédatifs. L'invention concerne en outre un produit comprenant un récipient doté d'une ouverture refermable contenant de 5 à 50 ml, de préférence de 10 à 20 ml, d'une formulation pharmaceutique comprenant de la buprénorphine ou l'un de ses sels acceptables pharmaceutiquement et un alcool, de préférence l'alcool benzylique.
PCT/EP2009/009196 2008-12-22 2009-12-21 Formulations vétérinaires Ceased WO2010072398A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08254107 2008-12-22
EP08254107.9 2008-12-22

Publications (2)

Publication Number Publication Date
WO2010072398A2 WO2010072398A2 (fr) 2010-07-01
WO2010072398A3 true WO2010072398A3 (fr) 2010-11-25

Family

ID=40655918

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/009196 Ceased WO2010072398A2 (fr) 2008-12-22 2009-12-21 Formulations vétérinaires

Country Status (1)

Country Link
WO (1) WO2010072398A2 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069600A2 (fr) * 1981-07-10 1983-01-12 Reckitt And Colman Products Limited Compositions pharmaceutiques
WO2003080022A2 (fr) * 2002-03-19 2003-10-02 Ionix Pharmaceuticals Limited Analgesiques
US20070117828A1 (en) * 2005-11-21 2007-05-24 Schering-Plough Animal Health Corp. Pharmaceutical compositions
WO2008047163A1 (fr) * 2006-10-18 2008-04-24 Pharmasol Limited Composition de pulvérisation sans pressurisation contenant de la buprénorphine pour administration par voie transmuqueuse
WO2008106571A2 (fr) * 2007-02-28 2008-09-04 Abbott Laboratories Formulations parentérales de buprénorphine à libération prolongée

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069600A2 (fr) * 1981-07-10 1983-01-12 Reckitt And Colman Products Limited Compositions pharmaceutiques
WO2003080022A2 (fr) * 2002-03-19 2003-10-02 Ionix Pharmaceuticals Limited Analgesiques
US20070117828A1 (en) * 2005-11-21 2007-05-24 Schering-Plough Animal Health Corp. Pharmaceutical compositions
WO2008047163A1 (fr) * 2006-10-18 2008-04-24 Pharmasol Limited Composition de pulvérisation sans pressurisation contenant de la buprénorphine pour administration par voie transmuqueuse
WO2008106571A2 (fr) * 2007-02-28 2008-09-04 Abbott Laboratories Formulations parentérales de buprénorphine à libération prolongée

Also Published As

Publication number Publication date
WO2010072398A2 (fr) 2010-07-01

Similar Documents

Publication Publication Date Title
WO2010065709A3 (fr) Dérivés d'acide hydroxamique, préparation et utilisations thérapeutiques de ceux-ci
WO2007146248A3 (fr) Préparations de laquinimod stables
WO2012021715A3 (fr) Formulations stables de linaclotide
WO2009103884A3 (fr) Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures
WO2010021607A3 (fr) Préparation pharmaceutique
WO2007127158A3 (fr) Modification d'absorption percutanée de matériaux topiquement actifs
IL196891A (en) Annals @@@ - Amino - @@@@@@@ - Tetrahydro - H9 - Carbazole - 9 - Yl) - Acetic Acid, Containing Pharmaceuticals
WO2012064126A3 (fr) Composition d'adhésif médical
IL192670A (en) Carboxylic Acids of 1, 3-Dioxane, Process for Preparation, Pharmaceutical Preparations Containing and Using it for Medication
WO2010016686A3 (fr) Nanoémulsion pour une administration locale
WO2010072958A3 (fr) Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
WO2009141541A3 (fr) Utilisation d' inhibiteurs de kif13a et d ' ap-1 pour inhiber la melanogenese
WO2011141488A3 (fr) Compositions pharmaceutiques comprenant de l'hydromorphone et de la naloxone
WO2012130820A3 (fr) Esters d'isopentyle à utiliser dans des compositions cosmétiques, dermatologiques ou pharmaceutiques
WO2008113901A3 (fr) Composition à libération prolongée de lévétiracetam et procédé de préparation.
WO2009060952A1 (fr) Nouvelle préparation
WO2010041832A3 (fr) Composition antioxydante active contenant un composé dériivé d'ishige okamurae
WO2012161497A3 (fr) Dérivés peptidiques ayant un effet hydratant supérieur et leurs utilisations
WO2008107092A3 (fr) Utilisation de dérivés d'acide 4-hydroxyphénoxy acétique
IL178425A0 (en) Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2011002422A3 (fr) Formulation pharmaceutique améliorant la solubilité
MX2009003060A (es) Emulsion.
EP2196463A4 (fr) Procédé de préparation d'acide 5,6-diméthylxanthone-acétique, dérivés ainsi obtenus et formulations pharmaceutiques de ceux-ci
WO2008092219A3 (fr) Composition pharmaceutique comprenant du tramadol et du cétoprofène en association

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09795724

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09795724

Country of ref document: EP

Kind code of ref document: A2